Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Zamuner

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Bulletin of Mathematical Biology|December 19, 2021
Correction to: Mathematical Modelling of Alternative Pathway of Complement SystemSuruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, et al.
Bulletin of Mathematical Biology|February 17, 2020
Mathematical Modelling of Alternative Pathway of Complement SystemSuruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, et al.
Synapse (New York, N.Y.)|June 21, 2011
Translational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1Roger N Gunn, Venkatesha Murthy, Ana M Catafau, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesEmiliangelo Ratti, Paolo Bettica, Robert Alexander, et al.
British Journal of Clinical Pharmacology|December 20, 2018
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patientsGeorgios Vlasakakis, Antonella Napolitano, Ruth Barnard, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 14, 2010
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancySergio Abanades, Jasper van der Aart, Julien A R Barletta, et al.
The Journal of Clinical Investigation|March 28, 2023
CERT1 mutations perturb human development by disrupting sphingolipid homeostasisCharlotte Gehin, Museer A Lone, Winston Lee, et al.
The Journal of Clinical Investigation|November 3, 2025
Corrigendum to CERT1 mutations perturb human development by disrupting sphingolipid homeostasisCharlotte Gehin, Museer A Lone, Winston Lee, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bulletin of Mathematical Biology|December 19, 2021
Correction to: Mathematical Modelling of Alternative Pathway of Complement SystemSuruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, et al.
Bulletin of Mathematical Biology|February 17, 2020
Mathematical Modelling of Alternative Pathway of Complement SystemSuruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, et al.
Synapse (New York, N.Y.)|June 21, 2011
Translational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1Roger N Gunn, Venkatesha Murthy, Ana M Catafau, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesEmiliangelo Ratti, Paolo Bettica, Robert Alexander, et al.
British Journal of Clinical Pharmacology|December 20, 2018
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patientsGeorgios Vlasakakis, Antonella Napolitano, Ruth Barnard, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 14, 2010
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancySergio Abanades, Jasper van der Aart, Julien A R Barletta, et al.
The Journal of Clinical Investigation|March 28, 2023
CERT1 mutations perturb human development by disrupting sphingolipid homeostasisCharlotte Gehin, Museer A Lone, Winston Lee, et al.
The Journal of Clinical Investigation|November 3, 2025
Corrigendum to CERT1 mutations perturb human development by disrupting sphingolipid homeostasisCharlotte Gehin, Museer A Lone, Winston Lee, et al.
Pageof 5